CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced the appointment of Matthias Jaffe to chief financial officer and vice president of business development. Mr. Jaffe brings to Zafgen extensive finance, acquisition and business development experience.
